Wellcome trust genome-wide association study of ischemic stroke

Stroke

Volumn 44, Issue SUPPL. 1, 2013, Pages

  Markus, Hugh S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Genetics; Histone deacetylase 9; Risk factors

Indexed keywords

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TECHNOLOGY; DRUG ANTAGONISM; HUMAN; REVIEW; RISK FACTOR; TWINS;

ANTICONVULSIVE AGENT; HDAC9 PROTEIN, HUMAN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 9; HISTONE DEACETYLASE INHIBITOR; REPRESSOR PROTEIN;

GENETICS; HISTONE DEACETYLASE 9; RISK FACTORS;

ANTICONVULSANTS; BRAIN ISCHEMIA; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; REPRESSOR PROTEINS; RISK FACTORS; STROKE; TWIN STUDIES AS TOPIC;

EID: 84880259302     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.680652     Document Type: Conference Paper

References (20)

1. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35:212-227.
2. Jerrard-Dunne P, Cloud G, Hassan A, Markus HS. Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke. 2003;34:1364-1369.
3. Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke. 2005;36:2027-2031.
4. Hindorff LA, MacArthur J (European Bioinformatics Institute), Wise A, Junkins HA, Hall PN, Klemm AK, Manolio TA. A Catalog of Published Genome-Wide Association Studies. www.genome.gov/gwastudies. Accessed August 11, 2012.
5. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A, et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol. 2008;64:402-409.
6. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet. 2009;41:876-878.
7. Lemmens R, Buysschaert I, Geelen V, Fernandez-Cadenas I, Montaner J, Schmidt H, et al International Stroke Genetics Consortium. The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke. 2010;41:1850-1857.
8. Schunkert H, Götz A, Braund P, McGinnis R, Tregouet DA, Mangino M, et al Cardiogenics Consortium. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation. 2008;117:1675-1684.
9. Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, Ross-Adams H, et al International Stroke Genetics Consortium. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol. 2009;65:531-539.
10. Helgadottir A, Thorleifsson G, Magnusson KP, Grétarsdottir S, Steinthorsdottir V, Manolescu A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40:217-224.
11. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44:328-33.
12. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32-42.
13. Langley B, Brochier C, Rivieccio MA. Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke. 2009;40:2899-2905.
14. Markus HS, Mäkelä KM, Bevan S, Raitoharju E, Oksala N, Bis JC, O'Donnell C, Hainsworth A, Lehtimäki T. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke. 2013 Feb28. [Epub ahead of print
15. Bowes AJ, Khan MI, Shi Y, Robertson L, Werstuck GH. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis. Am J Pathol. 2009;174:330-342.
16. Olesen JB, Abildstrøm SZ, Erdal J, Gislason GH, Weeke P, Andersson C, et al. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2011;20:964-971.
17. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell, JC, Cheng Y, et al. Genome-wide Associations with ischaemic stroke and its subtypes-the METASTROKE Collaboration. Lancet Neurol 2012;11: 951-62.
18. Hassan A, Sham PC, Markus HS. Planning genetic studies in human stroke: sample size estimates based on family history data. Neurology 2002;58:1483-1488.
19. Kraft P, Hunter DJ.Genetic risk prediction-are we there yet? N Engl J Med 2009;360:1701-1703.
20. Hirschhorn JN. Genomewide association studies -illuminating biological pathways. New Eng J Med 2009;360:1699-1701.